Developing an Intact Molecule Approach for Biopharmaceutical Analysis using High Resolution Mass Spectrometry

1 August 2016

Dr John Kellie, Associate Fellow, Bioanalysis, Immunogenicity and Biomarkers, GSK, describes a robust method for the quantitation of whole molecule biopharmaceutical candidates using the Waters iKey separation technology and Synapt G2-Si HDMS system. Learn more about Dr Kellie’s research.